Latest filing published 05 Jun 2025 for Immunic, INC., €20k.
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Joerg Neermann is a declared insider of Immunic, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 23 November 2022 to 5 June 2025, the count stands at 5 filings.
The open-market record is one-sided, with 5 purchases worth €188k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2025: 2 purchases and no sales on the market.
A typical purchase (the median) is worth €41k. Clusters matter here: 5 out of 5 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 5 purchases show a median change of +37.0%, with the price up in 60% of them. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 5 June 2025 with an open-market purchase (€20k) in Immunic, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations